This HTML5 document contains 214 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n9http://dx.doi.org/10.4161/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q36214988
rdf:type
wikibase:Item
schema:description
2014年論文 գիտական հոդված artículo científico publicado en 2014 2014年論文 scientific article 2014년 논문 article científic artigo científico (publicado na 2014) ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artigo científico (publicado na 2014) 2014年论文 2014年論文 vědecký článek מאמר מדעי мақолаи илмӣ სამეცნიერო სტატია научни чланак wetenschappelijk artikel artikull shkencor επιστημονικό άρθρο 2014年论文 mokslinis straipsnis scienca artikolo 2014年论文 2014年論文 научна статия teaduslik artikkel videnskabelig artikel (udgivet 2014) artigo científico wissenschaftlicher Artikel articol științific vetenskaplig artikel مقالة علمية نشرت في عام 2014 artículu científicu espublizáu en 2014 научни чланак tieteellinen artikkeli 2014年论文 مقالهٔ علمی articolo scientifico vitskapeleg artikkel vedecký článok 2014 nî lūn-bûn 2014年の論文 bilimsel makale мақолаи илмӣ vitenskapelig artikkel bài báo khoa học article scientifique (publié 2014) artykuł naukowy artikulong pang-agham 2014年论文 article scientific 2014年論文 tudományos cikk научная статья บทความทางวิทยาศาสตร์ наукова стаття, опублікована в січні 2014 naučni članak سائنسی مضمون 2014年论文
p:P577
wds:Q36214988-38256403-6A24-474F-B7C6-FD6F19CEA803
wdt:P577
2014-01-01T00:00:00Z
p:P2860
wds:Q36214988-1FA76B5A-183D-4B25-B531-D2C5C5ECDEB5 wds:Q36214988-2C5A8DA7-96FD-4FD8-B2F2-A270AE85F9BD wds:Q36214988-37E908A2-E051-40DA-9FE8-F8D7E741DD4B wds:Q36214988-190869ED-DC21-4722-BFAC-C7EA7C8382D3 wds:Q36214988-199F873F-556F-40D0-9DDC-DA03CCCBF237 wds:Q36214988-1DDA81DE-42CA-4935-B755-890CFD587851 wds:Q36214988-085F0016-271E-4AC4-9D52-390122D427D1 wds:Q36214988-1166E924-4F1E-44E7-B800-D900F4CEAA43 wds:Q36214988-A0244F60-34D1-474F-B569-82A99371BD0D wds:Q36214988-A54C666C-B780-4E92-AAAE-5278A2FB54CD wds:Q36214988-A8324608-01C8-4205-A24D-25EB714EEA06 wds:Q36214988-A8E89C8F-2772-461D-9E95-2A6201B7B6F5 wds:Q36214988-98F1DEAB-1A79-45E9-B6F2-C3CC209A2BD6 wds:Q36214988-9E623415-8F7C-4FC3-BBDA-64DE3879E48A wds:Q36214988-92A0ED72-74D3-45D8-996A-99474D750DF9 wds:Q36214988-93A89EEE-2DF4-48DC-AF88-09AEB8DA095E wds:Q36214988-9532D12E-5C0B-4558-A29C-E20D56363113 wds:Q36214988-95C60EA6-35E2-4715-985C-6EE22BF630AB wds:Q36214988-901AF8AC-40E0-43A0-821C-5ED2C867E600 wds:Q36214988-91EF2187-0FA4-4CF5-B0A2-1C1FD14A62DB wds:Q36214988-7E1DEDC2-A483-450C-AB67-E6D713FB0D0D wds:Q36214988-53963DFF-1243-4089-A70E-2D35920CFB88 wds:Q36214988-579D0212-E9D9-436D-9EFA-5BD27A940CB6 wds:Q36214988-5BC79B93-1941-4CF5-BDED-02877DC41BA6 wds:Q36214988-6936CDDC-345C-49A7-AFEA-F915D08B51D6 wds:Q36214988-4CFF6AC7-E1D8-4EB7-AF7D-226CF1029A70 wds:Q36214988-500631C2-25F8-476E-A3B0-E05FFFE5D148 wds:Q36214988-527B39E3-78A5-4C70-8330-749792373854 wds:Q36214988-3DCD5B32-6009-43EF-9599-A07CD5418EED wds:Q36214988-40612C8A-3982-49BE-96F7-2F34CF01B39E wds:Q36214988-FE7BD674-854D-4852-99DB-13DCE60DB5D7 wds:Q36214988-F41477A5-4338-4C89-963E-BA2A700D4B29 wds:Q36214988-F6B657C2-45E8-448D-BC7B-8A2B0C8B0569 wds:Q36214988-F71482AB-5B2D-406D-97B2-6077BBA64140 wds:Q36214988-E6E9ED6C-CA1F-426E-9A30-0EBBF13CFF0E wds:Q36214988-DF94D4C1-1921-475F-95B0-CDF08990C8A7 wds:Q36214988-D27234A0-6229-4D84-B54F-77871D0A2E81 wds:Q36214988-D4FBC169-E630-41D3-8314-602BECEE6F1F wds:Q36214988-D9FCE089-3E7F-4036-985E-074AEA61A3C6 wds:Q36214988-B4E9ABFA-211E-43F8-AA9B-44D50BC42906 wds:Q36214988-CC30D14A-8380-49F3-BB82-60AB72C45637 wds:Q36214988-CDC9F0D0-79F9-4720-99B9-4758BB55F444 wds:Q36214988-AB1C237C-193D-47CD-95DF-F33638D7F740 wds:Q36214988-AB541480-F6B1-47D8-91DD-20194E0849C5 wds:Q36214988-B1A4F9F4-E530-49DF-AD5B-398DFCDA32D9
wdt:P2860
wd:Q24306670 wd:Q33716008 wd:Q46939157 wd:Q80422206 wd:Q43729716 wd:Q34989320 wd:Q42461882 wd:Q33348987 wd:Q33927553 wd:Q44680519 wd:Q39139025 wd:Q34789719 wd:Q73939153 wd:Q34743514 wd:Q74597459 wd:Q35768666 wd:Q40055296 wd:Q39950082 wd:Q29547625 wd:Q44419411 wd:Q57287268 wd:Q33897273 wd:Q40859015 wd:Q24794303 wd:Q27851576 wd:Q36028155 wd:Q34892916 wd:Q51815504 wd:Q34392709 wd:Q34360679 wd:Q37170846 wd:Q73253485 wd:Q39496658 wd:Q40902776 wd:Q28140238 wd:Q54355446 wd:Q39542130 wd:Q46219469 wd:Q36703428 wd:Q69089721 wd:Q34757332 wd:Q40309246 wd:Q38078400 wd:Q34063557 wd:Q40610420
p:P2093
wds:Q36214988-18F63CF5-826D-4888-88B4-1D1F1394DD96 wds:Q36214988-17081A69-566A-4B3F-94B8-F463A92EDA81 wds:Q36214988-DAA277C0-D033-4B58-9EF2-454C5A90ECFF wds:Q36214988-FF8C24F0-FABC-41ED-8884-6552137873CA wds:Q36214988-EEB89929-C0C4-45B9-972E-9B387E4C5437 wds:Q36214988-F620472B-B463-448C-B5B0-078B0D17D05E wds:Q36214988-883989A6-BC55-4528-A090-5925E2D5CE19 wds:Q36214988-71EB80D2-4ACD-4AE6-8C0E-E3A7485A278A wds:Q36214988-3CC815E9-31D6-4A07-9942-D3B7B24E2BD3 wds:Q36214988-8AEB70B0-A882-4322-A9B6-4DF8F6553EE3
wdt:P2093
André Pèlegrin Jean-Pierre Pouget Henri Vié Véronique Garambois Frédéric Bibeau Christian K Behrens Muriel Busson Béatrice Clémenceau Pauline Estupina Nathalie Kersual
rdfs:label
The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4. The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4. The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4.
skos:prefLabel
The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4. The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4. The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4.
schema:name
The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4. The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4. The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4.
p:P50
wds:Q36214988-4444D52D-E2FF-4AF7-B539-BF3870BB5259 wds:Q36214988-8D888281-B9B6-4CD0-8103-E9FD71D0D33B wds:Q36214988-ABE01205-0FB0-43AF-AC10-04CA43FD5A1D wds:Q36214988-057D52B0-F2A0-4009-8438-E170AB6D53AE
wdt:P50
wd:Q112178177 wd:Q80600903 wd:Q112178184 wd:Q58319073
p:P1476
wds:Q36214988-16B2E7DC-62B2-4566-AAF5-1AB50CEC8280
wdt:P1476
The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4
p:P304
wds:Q36214988-3EE33BA3-75DA-40CC-AAA8-EB06469D8CA7
wdt:P304
1314-1326
p:P31
wds:Q36214988-EC408CE1-ED13-4C8A-B4F3-414810E38EDC
wdt:P31
wd:Q13442814
p:P921
wds:Q36214988-DB042148-A3B4-4939-AC70-4E731AC9030F wds:Q36214988-99AF1DA7-ADD4-4883-91B8-A1C4828B6445
wdt:P921
wd:Q1427096 wd:Q172341
p:P698
wds:Q36214988-C9D23BF2-EDCE-4D96-9968-BCB1B52352F2
wdtn:P698
n11:25517316
wdt:P698
25517316
p:P1433
wds:Q36214988-9DCEB088-420E-4296-9832-51B6A87C9A66
wdt:P1433
wd:Q6714645
p:P433
wds:Q36214988-EEDAF19D-0107-4377-8BF5-70FD04D48591
p:P478
wds:Q36214988-E4D775DB-B2C2-438E-AC30-D5F228335B68
wdt:P433
5
wdt:P478
6
p:P356
wds:Q36214988-D9AA4278-76C3-4DEC-8C80-DF9E45414DE6
wdtn:P356
n9:MABS.29316
wdt:P356
10.4161/MABS.29316
p:P932
wds:Q36214988-858501F9-2E70-41F2-9F11-16FAE534E6CB
wdt:P932
4623115